Annexon, Inc. Announces 2024 Annual Meeting of Stockholders on June 5, 2024
Ticker: ANNX · Form: DEF 14A · Filed: Apr 25, 2024 · CIK: 1528115
Sentiment: neutral
Topics: Annexon, ANNX, Proxy Statement, Annual Meeting, KPMG LLP
TL;DR
<b>Annexon, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 5, 2024, to elect directors, ratify auditors, and vote on executive compensation.</b>
AI Summary
Annexon, Inc. (ANNX) filed a Proxy Statement (DEF 14A) with the SEC on April 25, 2024. Annexon, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 5, 2024, at 8:00 a.m. Pacific Time. The meeting agenda includes the election of two Class I directors, ratification of KPMG LLP as the independent auditor for fiscal year 2024, and an advisory vote on executive compensation. The record date for determining stockholders eligible to vote is April 8, 2024. Stockholders can attend the virtual meeting via webcast at www.virtualshareholdermeeting.com/ANNX2024 using a provided control number. The company is incorporated in Delaware and operates in the Pharmaceutical Preparations industry.
Why It Matters
For investors and stakeholders tracking Annexon, Inc., this filing contains several important signals. This filing is a proxy statement, indicating key corporate governance decisions are being presented to shareholders for a vote. The virtual format for the annual meeting suggests a focus on accessibility and potentially cost-efficiency in shareholder engagement.
Risk Assessment
Risk Level: low — Annexon, Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting and does not contain new financial or operational information that would indicate significant risk.
Analyst Insight
Review the director nominees and executive compensation proposals to understand Annexon's governance and compensation strategies.
Key Numbers
- June 5, 2024 — Annual Meeting Date (2024 Annual Meeting of Stockholders)
- April 8, 2024 — Record Date (Stockholders of record on this date may vote)
- 2 — Class I Director Nominees (To be elected at the Annual Meeting)
- 2024 — Fiscal Year for Auditor Ratification (KPMG LLP as independent auditor for fiscal year ending December 31, 2024)
Key Players & Entities
- Annexon, Inc. (company) — Registrant
- KPMG LLP (company) — independent registered public accounting firm
- June 5, 2024 (date) — 2024 Annual Meeting of Stockholders
- April 8, 2024 (date) — record date for the Annual Meeting
- 2027 (date) — term for Class I directors
- 2024 (date) — fiscal year ending December 31, 2024
- 1400 Sierra Point Parkway, Bldg C, Suite 200 Brisbane, California 94005 (address) — Company Business Address
FAQ
When did Annexon, Inc. file this DEF 14A?
Annexon, Inc. filed this Proxy Statement (DEF 14A) with the SEC on April 25, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Annexon, Inc. (ANNX).
Where can I read the original DEF 14A filing from Annexon, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Annexon, Inc..
What are the key takeaways from Annexon, Inc.'s DEF 14A?
Annexon, Inc. filed this DEF 14A on April 25, 2024. Key takeaways: Annexon, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 5, 2024, at 8:00 a.m. Pacific Time.. The meeting agenda includes the election of two Class I directors, ratification of KPMG LLP as the independent auditor for fiscal year 2024, and an advisory vote on executive compensation.. The record date for determining stockholders eligible to vote is April 8, 2024..
Is Annexon, Inc. a risky investment based on this filing?
Based on this DEF 14A, Annexon, Inc. presents a relatively low-risk profile. The filing is a routine proxy statement for an annual meeting and does not contain new financial or operational information that would indicate significant risk.
What should investors do after reading Annexon, Inc.'s DEF 14A?
Review the director nominees and executive compensation proposals to understand Annexon's governance and compensation strategies. The overall sentiment from this filing is neutral.
How does Annexon, Inc. compare to its industry peers?
Annexon, Inc. operates in the pharmaceutical preparations industry, focusing on developing therapies.
Are there regulatory concerns for Annexon, Inc.?
The filing is made under the Securities Exchange Act of 1934, specifically Schedule 14A, governing proxy solicitations.
Risk Factors
- Regulatory Compliance [low — regulatory]: The company must comply with SEC regulations regarding proxy solicitations and annual meetings.
- Virtual Meeting Execution [low — operational]: Ensuring a smooth and accessible virtual meeting experience for all stockholders is crucial.
- Auditor Independence and Effectiveness [low — financial]: The ratification of KPMG LLP as the independent auditor is subject to shareholder approval and impacts financial reporting integrity.
Industry Context
Annexon, Inc. operates in the pharmaceutical preparations industry, focusing on developing therapies.
Regulatory Implications
The filing is made under the Securities Exchange Act of 1934, specifically Schedule 14A, governing proxy solicitations.
What Investors Should Do
- Review the biographies and qualifications of the director nominees.
- Examine the details of the executive compensation plan being presented for advisory approval.
- Confirm the ratification of KPMG LLP as the independent auditor for fiscal year 2024.
Key Dates
- 2024-06-05: 2024 Annual Meeting of Stockholders — Key date for voting on director nominees, auditor ratification, and executive compensation.
- 2024-04-08: Record Date — Determines which stockholders are eligible to vote at the Annual Meeting.
Year-Over-Year Comparison
This is a DEF 14A filing, a proxy statement for the annual meeting, and does not contain comparative financial data from a previous filing.
Filing Stats: 4,679 words · 19 min read · ~16 pages · Grade level 11.6 · Accepted 2024-04-25 16:03:19
Filing Documents
- ny20020644x1_def14a.htm (DEF 14A) — 746KB
- ny20020644x1_pc01.jpg (GRAPHIC) — 600KB
- ny20020644x1_pc02.jpg (GRAPHIC) — 519KB
- ny20020644x1_pvp01.jpg (GRAPHIC) — 81KB
- ny20020644x1_pvp02.jpg (GRAPHIC) — 81KB
- sig_douglaslove.jpg (GRAPHIC) — 11KB
- 0001140361-24-022025.txt ( ) — 2526KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT ​ ​ 20 MANAGEMENT ​ ​ 23 SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE ​ ​ 24
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION ​ ​ 25 CERTAIN RELATIONSHIPS AND RELATED-PERSON TRANSACTIONS ​ ​ 36 HOUSEHOLDING ​ ​ 38 OTHER MATTERS ​ ​ 38 i TABLE OF CONTENTS ANNEXON, INC. 1400 Sierra Point Parkway, Bldg C, Suite 200 Brisbane, California 94005 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING Why did I receive a notice regarding the availability of proxy materials on the internet? Pursuant to rules adopted by the Securities and Exchange Commission (the “SEC”), we have elected to provide access to our proxy materials over the internet. Accordingly, we have sent you a Notice of Internet Availability of Proxy Materials (the “Notice”) because the Board of Directors (the “Board”) of Annexon, Inc. (sometimes referred to as the “Company” or “Annexon”) is soliciting your proxy to vote at the 2024 Annual Meeting of Stockholders (the “Annual Meeting”), including at any continuation, adjournment or postponement of the meeting. All stockholders will have the ability to access the proxy materials on the website referred to in the Notice or request to receive a printed set of the proxy materials. Instructions on how to access the proxy materials over the internet or to request a printed copy may be found in the Notice. We intend to mail the Notice on or about April 26, 2024 to all stockholders of record entitled to vote at the Annual Meeting. How do I attend the Annual Meeting? The meeting will be held virtually on Wednesday, June 5, 2024 at 8:00 a.m. Pacific Time at www.virtualshareholdermeeting.com/ANNX2024. There will be no physical meeting location. The meeting will be conducted only via an audio webcast. We believe that hosting a virtual meeting will facilitate stockholder attendance and participation at our annual meeting by enabling st